Patented Medicine Prices Review Board

Patented Medicine Prices Review Board

January 07, 2005 16:50 ET

The PMPRB to Hold a Public Hearing Into the Price of Evra


NEWS RELEASE TRANSMITTED BY CCNMatthews

FOR: PATENTED MEDICINE PRICES REVIEW BOARD

JANUARY 7, 2005 - 16:50 ET

The PMPRB to Hold a Public Hearing Into the Price of
Evra

OTTAWA, ONTARIO--(CCNMatthews - Jan. 7, 2005) - The Patented Medicine
Prices Review Board will hold a public hearing on May 11, 2005, in the
matter of Janssen-Ortho Inc. and the price of the medicine Evra. A
pre-hearing conference will be held on February 24, 2005.



The purpose of the hearing is to determine whether, under sections 83
and 85 of the Patent Act, Janssen-Ortho Inc.

- is selling or has sold the medicine known as Evra in any market
in Canada at a price that, in the Board's opinion, is or was
excessive; and,
- if so, what order, if any, should be made.


Evra is a transdermal contraceptive patch indicated for the prevention
of pregnancy in women who elect to use hormonal contraceptives.

Persons wishing to intervene in the proceeding are required to apply to
the Board for leave to intervene on or before January 25, 2005. Such
persons should contact the Secretary of the Board for further
information on the procedure.

The Notice of Hearing in this matter and Board Staff's Statement of
Allegations are available on the PMPRB website.

All requests for information should be addressed to the Secretary of the
Board.

-30-

Contact Information

  • FOR FURTHER INFORMATION PLEASE CONTACT:
    Patented Medicine Prices Review Board
    Sylvie Dupont
    Secretary
    1-877-861-2350 (Toll free)/(613) 954-8299 (Direct line)
    (613) 952-7626 (FAX)
    sdupont@pmprb-cepmb.gc.ca